TELORMEDIX
Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.
TELORMEDIX
Social Links:
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Bioggio, Ticino, Switzerland
Country:
Switzerland
Website Url:
http://www.telormedix.com
Total Employee:
1+
Status:
Active
Contact:
+1 918-681-9668
Email Addresses:
[email protected]
Total Funding:
33.8 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress LetsEncrypt SSL By Default Font Awesome Organization Schema Sitelinks Search Box
Similar Organizations
Acublate
Acublate developing a HIFU device used to treat various types of solid tumors.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Synthica Biotech
Synthica Biotech is a biopharmaceutical company that provides treatments to address unmet medical needs in dermato-oncological diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Founder
Investors List
ProQuest Investments
ProQuest Investments investment in Series B - Telormedix
Aravis Ventures
Aravis Ventures investment in Series B - Telormedix
Aravis Ventures
Aravis Ventures investment in Series B - Telormedix
ProQuest Investments
ProQuest Investments investment in Series B - Telormedix
Aravis Ventures
Aravis Ventures investment in Series A - Telormedix
ProQuest Investments
ProQuest Investments investment in Series A - Telormedix
Nextech Invest
Nextech Invest investment in Series A - Telormedix
BSI SA
BSI SA investment in Series A - Telormedix
Official Site Inspections
http://www.telormedix.com
- Host name: apache2-argon.iad1-shared-e1-13.dreamhost.com
- IP address: 173.236.195.208
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Telormedix"
Telormedix - Crunchbase Company Profile & Funding
Organization. Telormedix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Telormedix is a biopharmaceutical company …See details»
Telormedix SA - Bioggio, Switzerland - bionity.com
Aug 3, 2011 Telormedix is a clinical stage biopharmaceutical company founded in 2008 and focused on targeted immunity in the treatment of cancer and other diseases. Located in …See details»
Telormedix 2025 Company Profile: Valuation, Investors ... - PitchBook
Telormedix General Information Description. Developer of biopharmaceutical drugs intended to treat cancer and infectious diseases. The company's drugs developed with a new formulation …See details»
Telormedix - VentureRadar
Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. The Company’s lead …See details»
Organization | Telormedix SA
Telormedix SA Report issue. For profit Phase 2. Founded: Bioggio Switzerland ... Organization Overview. First Clinical Trial. 2013 NCT01731652. First Marketed Drug. None First NDA …See details»
Telormedix - Overview, News & Similar companies | ZoomInfo.com
Who is Telormedix. Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate …See details»
Telormedix SA Company Profile, Financial and Strategic SWOT
Telormedix SA, a biopharmaceutical company, develops immune-selective drugs for the treatment of cancer and autoimmune diseases. Its products include TMX-101 for the treatment of …See details»
Telormedix SA - Company Profile and News - Bloomberg Markets
Company profile page for Telormedix SA including stock price, company news, executives, board members, and contact informationSee details»
Telormedix SA - Venturelab
Jan 10, 2007 Telormedix SA. Incorporated 01.10.2007. Headquarters Bioggio. Support. Telormedix is a clinical stage biopharmaceutical company focused on targeted immunity in the …See details»
Telormedix Secures Further Funding | Fierce Biotech
Jan 10, 2012 Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate …See details»
Telormedix - Funding, Financials, Valuation & Investors - Crunchbase
Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases. New. Resources. Advanced Search. ... How much …See details»
Telormedix S.A. - BioCentury Company Profiles - BCIQ
Oct 20, 2014 Telormedix S.A. - BioCentury Company Profiles for the biopharma industrySee details»
Research programme: toll-like receptor 7 modulators - Telormedix …
Telormedix in Switzerland is developing second-generation, small-molecule toll-like receptor 7 (TLR7) modulators for the treatment of cancer (including bladder ... If your organization has a …See details»
Telormedix - VentureRadar
Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. The Company’s lead …See details»
Telormedix - Contacts, Employees, Board Members, Advisors
Organization. Telormedix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
UroGen Pharma acquires Telormedix - 2015-01-01 - Crunchbase
Jan 1, 2015 Telormedix Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases. Acquiring Organization: …See details»
Privacy Policy - telormedix.com
Dec 9, 2023 Welcome to https://www.telormedix.com (the “Site”). We understand that privacy online is important to users of our Site, especially when conducting business. This statement …See details»
Telormedix | VentureRadar
Similar Companies: INNATE PHARMA France Publicly Traded Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and …See details»
Telormedix SA - startup.ch
Telormedix’s Cancer Drug Successfully Completes Phase II Trials (startupticker.ch) 02.12.2013 Telormedix Raises CHF 6 M in Series B Financing Round (startupticker.ch)See details»
Telormedix’ TMX-101 Commences Clinical Trial for Bladder Cancer
Jun 14, 2010 Telormedix has developed TMX-101, a targeted therapy for the treatment of non muscle-invasive bladder cancer (NMIBC). The active ingredient of TMX-101 is a known …See details»